​

Funding Round

Series D - Orca Bio

Series D - Orca Bio

Investment Firm

Overview

Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to patients.

Announced Date

Jun 17, 2020

Funding Type

Series D

Highlights

Location

United States, North America

Social

N/A

Investor Lead

Lightspeed Venture Partners

Lightspeed Venture Partners

Lightspeed Venture Partners is a early_stage_venture and late_stage_venture and seed firm.

Participant Investors

11

Investor Name
Participant InvestorBlue Chip Venture Company
Participant Investor8VC
Participant InvestorFelicis
Participant InvestorLightspeed Venture Partners
Participant InvestorKaiser Permanente

Round Details and Background

Orca Bio raised $192000000 on 2020-06-17 in Series D

Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to patients.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 17, 2020
Series D - Orca Bio
11-192.0M
May 17, 2018
Series C - Orca Bio
1-undefined
May 01, 2016
Pre Seed Round - Orca Bio
1-undefined

Recent Activity

There is no recent news or activity for this profile.